Medical Creations

Market position

Xtremity positions XtremityTT as an alternative to conventional carbon fiber laminated definitive sockets in the transtibial O&P market, emphasizing heat adjustability and rapid fabrication rather than lower cost; it acknowledges higher up-front cost than in-house laminated fabrication. A third-party startup ranking listed Medical Creations among the top startups in Aspen, Colorado.

Differentiation rests on a definitive (not temporary) socket that remains heat-adjustable for the life of the prosthesis, roughly one-hour fabrication versus traditional lamination workflows, roughly 10-minute spot-heat adjustments, reduced clinician exposure to chemicals, fumes and carbon dust, less material waste, and claimed testing depth (30 million+ steps, ISO 10328 componentry, a 38-patient IRB-approved trial in which 81% of patients preferred the XtremityTT socket to a duplicated carbon fiber laminated socket).

Technology

The core technology is a proprietary thermoformable carbon-reinforced polymer that can be injection molded into a socket "preform." Clinicians apply heat to thermoform the preform to the patient's residual limb, then trim and assemble it; localized spot-heating enables later adjustments. The design includes modular, interchangeable suspension systems (pin-lock, suction, vacuum) and adjustment tolerances of up to 16mm slide and 30 degrees rotation. The company reports rigorous durability and thermal testing, with componentry meeting ISO 10328 standards, and describes the fabrication process as eliminating variables and reducing hazardous exposures relative to lamination and grinding.

Go-to-market

Direct sales through a U.S. field organization organized by territory, including a National Sales Director, a Director of Key Accounts and regional sales managers covering the Northeast, Mid-Atlantic, Southeast, South-Central, Midwest and West Coast states. Adoption is supported by Clinical Specialists who provide education and training to prosthetists and technicians introducing the system into their clinics, alongside patient testimonial content and clinical trial results on the company site.

Orthotic and prosthetic providers, prosthetists and technicians, and clinics serving adults and children with transtibial limb loss or limb difference; end users are transtibial amputees.

Geography

Headquartered in Aspen, Colorado, with an address in Denver, Colorado listed on SEC Form D filings. Products are designed, tested and manufactured in the United States, and the sales organization covers U.S. territories spanning the Northeast, Mid-Atlantic, Southeast, South-Central, Midwest and West Coast. The company describes humanitarian involvement abroad, including support for Ukrainian prosthetics charities such as the Protez Foundation, and a founding mission oriented toward countries with limited access to prosthetic care.

History

Since its 2017 founding the company has pursued a staged path from concept to commercialization, filing four SEC Form D equity offerings between February 2018 and June 2021 totaling roughly $17.9 million reported sold. Maynard Carkhuff, a prosthetics-industry executive with more than 30 years of experience who previously led Flex-Foot, Inc. and Freedom Innovations, joined as President and CEO in 2021 and was credited with helping secure additional investor funding and guiding commercialization of the XtremityTT Socket System. Clinical Specialist Mark Clary joined in 2022 as the company built out clinician education and training. The company has recruited patient testers, run durability, thermal and clinical testing, and established operations, quality systems, customer service and order fulfillment capabilities.

Risks & controversies

The sources disclose no litigation or controversies. Noted business risks are inherent in the material: the company states its system carries higher up-front cost than in-house carbon fiber lamination, which may slow clinic adoption; efficacy and durability claims rest largely on company-reported testing and a single 38-patient IRB-approved trial; and public information is limited, with one third-party directory still describing Medical Creations as a stealth healthcare company with 1-10 employees and listing an unverified executive.